Cisco Systems Inc
Change company Symbol lookup
Select an option...
CSCO Cisco Systems Inc
HMNF HMN Financial Inc
BAM Brookfield Asset Management Inc
XOM Exxon Mobil Corp
NEWR New Relic Inc
T AT&T Inc
AICAF Air China Ltd
MMM 3M Co
JNJ Johnson & Johnson
TIP iShares TIPS Bond ETF
Go

Information Technology : Communications Equipment | Large Cap Value
Company profile

Cisco Systems, Inc., is engaged in designing and selling a range of technologies across networking, security, collaboration, applications and the cloud. It operates through three geographic segments: Americas; Europe, Middle East, and Africa; and Asia Pacific, Japan, and China. Its product and technologies include infrastructure platforms; applications; security and other products. Infrastructure Platforms consists of its core networking technologies of switching, routing, data center products and wireless that are designed to work together to deliver networking capabilities and transport and store data. Application product category consists primarily of software-related offerings that utilize the core networking and data center platforms to provide their functions. Security product category primarily includes unified threat management products, threat security products and Web security products. Its subsidiary, ThousandEyes, Inc., offers Internet and cloud intelligence platform.

Postmarket

Last Trade
Delayed
$39.11
0.05 (0.13%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$39.06
Day's Change
-0.07 (-0.18%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
39.38
Day's Low
38.83
Volume
(Light)
Volume:
16,355,158

10-day average volume:
25,917,095
16,355,158

Vaccines Market to Reach USD 104.87 Billion by 2027; Introduction of World's First Malaria Vaccine in Malawi to Lighten Business Possibilities, states Fortune Business Insights(TM)

9:47 am ET July 16, 2020 (Globe Newswire) Print

The global vaccines market size is expected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7% during the forecast period. The ongoing clinical trials for COVID-19 vaccine will have a tremendous impact on the global market during the forecast period, states Fortune Business Insights in a report, titled "Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases (Hepatitis, Influenza, Human Papillomavirus, Measles/Mumps/Rubella, Rotavirus, Herpes Zoster, and Others) and Bacterial Diseases (Meningococcal Disease, Pneumococcal Disease, Diphtheria/Tetanus/Pertussis, and Others)), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Region Forecast, 2020-2027" the market size stood at USD 46.88 billion in 2019.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vaccines-market-101769

This market report sheds light on:

-- Thorough analysis of all the parts

-- Enlightening data and figures

-- In-depth information about industry players

-- Progressing developments in the industry

-- COVID-19 impact on the market

Market Driver:

Strong Demand for Pocket-friendly Immunization to Boost Growth

The increasing supply of various products to cater to the need of patients will have a positive influence on the market. The surge in unmet needs along with the global aim to eradicate endemic diseases will encourage the development of vaccines. The united focus of pharmaceutical companies, government foundations, international organizations, and hospitals towards cost-effective vaccines and immunization therapies for people around the world.

The active government scrutiny for vaccines at a minimum cost or no cost for every individual will further incite market development in the forthcoming years. For instance, the pneumococcal conjugate vaccine was rolled out by the Universal Immunization Programme (UPI) to 21 lakh children in Himachal Pradesh and parts of Bihar in India. The increasing R&D investment by companies for novel products will further escalate market demand, which, in turn, will bode well for the market.

The whole world is battling with the newly originated virus. The authorities of several countries have initiated lockdown to prevent the spread of coronavirus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

To get to know more about the short-term and long-term impacts of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769

Market Restraint:

Low Adoption of Vaccines Amid COVID-19

The postponement of immunization campaigns and reduction in the vaccination rate during pandemic has produced major concerns. According to the GAVI, the ceasing of immunizations will result in a lack of vaccination for 13.5 million people from the least developed countries. The decline in pneumococcal vaccine supply will further limit market expansion during coronavirus pandemic.

The lower adoption of vaccines in lower- and middle-income nations will subsequently dampen the growth of the market. However, the potential pipeline drugs for coronavirus is expected to contribute enormously to the growth of the market. For Pfizer, Johnson and Johnson, and other players are running clinical trials for potential candidates, which will soon be released after regulatory approvals.

Regional Analysis:

Presence of Eminent Manufacturers to Influence Growth in North America

The market in North America generated a revenue of USD 24.88 billion in 2019 and is expected to remain dominant during the forecast period. The growth in the region is attributed to the presence of key manufacturers in the region. The increasing awareness regarding vaccination along with secure government policies for healthcare will further support expansion in the region.

Asia Pacific is expected to witness a rapid growth rate during the forecast period due to the increasing population in India and China. The growing demand for vaccines will have a positive effect on the market. Europe is expected to account for a significant share owing to the increasing demand for immunization. The prevalence of chronic diseases will spur opportunities for the market in the region.

Quick Buy - Vaccines Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101769

Key Development:

April 2019: World Health Organization (WHO) approved the world's first malaria vaccine by the government of Malawi's landmark pilot program launched in Africa.

List of the Leading Companies Profiled in the Vaccines Market Research Report are:

-- GlaxoSmithKline plc. (Brentford, United Kingdom)

-- Sanofi (Paris, France)

-- Pfizer Inc. (New York, United States)

-- Merck & Co., Inc. (New Jersey, United States)

-- Novartis AG (Basel, Switzerland)

-- Emergent BioSolutions, Inc. (Maryland, United States)

-- CSL Limited (Melbourne, Australia)

-- Inovio Pharmaceuticals, Inc. (Pennsylvania, United States)

-- Bavarian Nordic (Denmark)

-- Mitsubishi Tanabe Pharma Corporation (Osaka, Japan)

-- Other Prominent Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/vaccines-market-101769

Detailed Table of Content:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- New Product Launches, key players

        -- New Product Launches, key players

        -- Pipeline Analysis

        -- Technological Advancements in the Vaccines Market

        -- Prevalence of Disease Indications

        -- Key Industry Developments - Mergers, Acquisitions, and Partnerships

        -- Global Vaccines Market Analysis, Insights and Forecast, 2016-2027

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Type

            -- Recombinant/Conjugate/Subunit

            -- Recombinant/Conjugate/Subunit

            -- Inactivated

            -- Live Attenuated

            -- Toxoid

            -- Market Analysis, Insights and Forecast - By Route of Administration

              -- Parenteral

              -- Parenteral

              -- Oral

              -- Market Analysis, Insights and Forecast - By Disease Indication

                -- Viral Diseases

                  -- Viral Diseases

                    -- Hepatitis

                    -- Influenza

                    -- Human Papillomavirus

                    -- Measles/Mumps/Rubella

                    -- Rotavirus

                    -- Herpes Zoster

                    -- Others

                    -- Bacterial Diseases

                      -- Meningococcal Disease

                      -- Meningococcal Disease

                      -- Pneumococcal Disease

                      -- Diphtheria/Tetanus/Pertussis

                      -- Others

                      -- Market Analysis, Insights and Forecast - By Age Group

                        -- Pediatric

                        -- Pediatric

                        -- Adults

                        -- Market Analysis, Insights and Forecast - By Distribution Channel

                          -- Hospital & Retail Pharmacies

                          -- Hospital & Retail Pharmacies

                          -- Government Suppliers

                          -- Others

                          -- Market Analysis, Insights and Forecast - By Geography

                            -- North America

                            -- North America

                            -- Europe

                            -- Asia pacific

                            -- Latin America

                            -- Middle East & Africa

                            TOC Continued...!!!

                            Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/vaccines-market-101769

                            Have a Look at Related Reports:

                            Veterinary/Animal Vaccines Market Size, Share & Industry Analysis, By Product (Inactivated, Live Attenuated, Recombinant, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2026

                            Pediatric Drugs and Vaccines Market Size, Share and Global Trend By Product (Vaccines, Drugs) By Disease Indication (Infectious Disease, Cancer, Allergy And Respiratory, Nervous System Disorders, Cardiovascular Disease, Diabetes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026

                            Recombinant DNA Technology Market Size, Share and Global Trend By Product (Vaccines, Therapeutic Agents, Recombinant Protein, Others), By Component (Vectors, Expression System, Others), By Application (Diagnostics, Therapeutic, Food and Agriculture, Others), By End User (Biotechnology and Pharmaceutical Companies, Diagnostic Laboratories, Academic and Government Research Institutes, Other) and Geography Forecast till 2026

                            Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2019-2026

                            Livestock Vaccines MarketSize, Share & Industry Analysis, By Animal Type (Cattle, Horses, Pigs,others), By Vaccine Type (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), By Route of Administration (Oral, Intravenous), By Disease Indication (Clostridial Diseases, Reproductive and Infertility Disease, others) By Distribution Channel (Veterinary Hospital Pharmacies, Regional Distribution Centers) and Regional Forecast, 2019-2026

                            Veterinary Vaccine Adjuvants Market Size, Share & Industry Analysis, By Type (Alum and Calcium Salts, Oil Emulsion Adjuvants, Liposomes, and Archaeosomes, Nanoparticles and Mi-croparticles, and Others), By Application (Research, and Commercial), By Route of Admin-istration (Oral, Subcutaneous, Intramuscular, and Others), By Animal Type (Livestock Animal, and Companion Animal) and Regional Forecast, 2020-2027

                            Recombinant Vaccines MarketSize, Share & Industry Analysis, By Type (Subunit and Live Attenuated), By Route of Administration (Parenteral and Oral), By Disease Indication (Human Papillomavirus, Hepatitis B, Rotavirus, Herpes Zoster, Meningococcal B, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2019-2026

                            About Us:

                            Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                            Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                            At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                            Contact Us:

                            Fortune Business Insights(TM) Pvt. Ltd.

                            308, Supreme Headquarters,

                            Survey No. 36, Baner,

                            Pune-Bangalore Highway,

                            Pune - 411045, Maharashtra, India.

                            Phone:

                            US :+1 424 253 0390

                            UK : +44 2071 939123

                            APAC : +91 744 740 1245

                            Email: sales@fortunebusinessinsights.com

                            Fortune Business Insights(TM)

                            LinkedIn | Twitter | Blogs

                            Press Release: https://www.fortunebusinessinsights.com/press-release/vaccines-market-9430

                            https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

                            comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.